公开(公告)号：WO2022053486A1

公开(公告)日：2022-03-17

申请号：PCT/EP2021/074661

申请日：2021-09-08

申请人： GW RESEARCH LIMITED

发明人： CRAIG, Kevin, James ,  LAWSON, John, Anthony

IPC分类号： A61K31/05 ,  A61K45/06 ,  A61P25/08

摘要： The present invention relates to the use of cannabidivarin (CBDV) for the treatment of seizures associated with rare epilepsy syndromes. In particular the seizures associated with rare epilepsy syndromes that are treated are those which are experienced in patients diagnosed with Rett syndrome. In a further embodiment the types of seizures include focal motor seizures with impairment, focal non-motor seizures with impairment, generalised motor seizures, generalised non-motor seizures, unknown onset motor seizures, and non-motor seizures. Preferably the dose of CBDV is between 2.5 mg/kg/day to 10 mg/kg/day.